The Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2
Free

The Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2

By Various
Free
Book Description
Table of Contents
  • THE PROPAGANDA FOR REFORM IN Proprietary Medicines
  • PREFACE TO VOLUME 2
  • PREFACE TO VOLUME 1: NINTH EDITION
  • RESOLUTION ENDORSING THE WORK OF THE COUNCIL ON PHARMACY AND CHEMISTRY
    • Presented at the San Francisco Session and Signed by All the Members of the House of Delegates in Attendance
  • TABLE OF CONTENTS
  • PART I REPORTS OF THE COUNCIL ON PHARMACY AND CHEMISTRY
  • FOREWORD
    • THE COUNCIL ON PHARMACY AND CHEMISTRY
    • OFFICIAL RULES OF THE COUNCIL ON PHARMACY AND CHEMISTRY
      • Introduction
      • Rules Governing the Admission of Proprietary Articles to the Book New and Non­official Remedies
      • Explanatory Comments on the Rules
      • Explanation of Rule 1: Composition
      • Explanation of Rule 2: Identification
      • Explanation of Rule 3: Direct Advertising
      • Explanation of Rule 4: Indirect Advertising
      • Explanation of Rule 5: False Claims as to Origin
      • Explanation of Rule 6: Unwarranted Therapeutic Claims
      • Explanation of Rule 7: Poisonous Substances
      • Explanation of Rule 8: Objectionable Names
      • Explanation of Rule 9: Patents, Trademarks, Copyrights, Etc.
      • Explanation of Rule 10: Unscientific and Useless Articles
    • Introduction
    • Rules Governing the Admission of Proprietary Articles to the Book New and Non­official Remedies
    • Explanatory Comments on the Rules
    • Explanation of Rule 1: Composition
    • Explanation of Rule 2: Identification
    • Explanation of Rule 3: Direct Advertising
    • Explanation of Rule 4: Indirect Advertising
    • Explanation of Rule 5: False Claims as to Origin
    • Explanation of Rule 6: Unwarranted Therapeutic Claims
    • Explanation of Rule 7: Poisonous Substances
    • Explanation of Rule 8: Objectionable Names
    • Explanation of Rule 9: Patents, Trademarks, Copyrights, Etc.
    • Explanation of Rule 10: Unscientific and Useless Articles
    • THE COUNCIL ON PHARMACY AND CHEMISTRY, PRESENT AND FUTURE [A]
    • “ACCEPTED BY THE COUNCIL ON PHARMACY AND CHEMISTRY”
    • HELPING THE COUNCIL
    • DELAYS IN PASSING ON PRODUCTS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • COOPERATION OF THE PHARMACEUTICAL HOUSES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • BUDWELL’S EMULSION OF COD-LIVER OIL, NOS. 1 AND 2
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • RHEUMALGINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • GRAY’S GLYCERINE TONIC
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TONGALINE AND PONCA COMPOUND
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ALFATONE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ARTICLES REFUSED RECOGNITION
      • Report of the Council on Pharmacy and Chemistry
      • Uricsol
      • Jubol
      • Urodonal
    • Report of the Council on Pharmacy and Chemistry
    • Uricsol
    • Jubol
    • Urodonal
    • FORMAMINT
      • Report of the Council on Pharmacy and Chemistry
      • Experimental Data
      • Discussion
    • Report of the Council on Pharmacy and Chemistry
    • Experimental Data
    • Discussion
    • HYDRAGOGIN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FILUDINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • LACTOPEPTINE AND ELIXIR LACTOPEPTINE
      • Report of the Council on Pharmacy and Chemistry
      • Manufacturers’ Protest and Council’s Answer
      • Report of Referee A
      • Report of Referee B
    • Report of the Council on Pharmacy and Chemistry
    • Manufacturers’ Protest and Council’s Answer
    • Report of Referee A
    • Report of Referee B
    • IODUM-MILLER AND IOD-IZD-OIL (MILLER’S)
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ELIXIR IODO-BROMIDE OF CALCIUM COMP. “WITHOUT MERCURY” AND “WITH MERCURY”
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • LECITHIN PREPARATIONS OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
      • Lecithin Preparations
    • Report of the Council on Pharmacy and Chemistry
    • Lecithin Preparations
    • PROPRIETARY NAMES FOR LIQUID PETROLATUM
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SENG
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FROSST’S BLAUD CAPSULES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TYREE’S ELIXIR OF BUCHU AND HYOSCYAMUS COMPOUND
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HYDROLEINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CURATIVE VACCINE, BRUSCHETTINI
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • STEARNS’ WINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PROTONUCLEIN AND PROTONUCLEIN BETA
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HYDROPSIN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • DIGITALYSATUM
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SO-CALLED SECRETIN PREPARATIONS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HAS SECRETIN A THERAPEUTIC VALUE? [B][C]
    • ARTICLES REFUSED RECOGNITION
      • Report of the Council on Pharmacy and Chemistry
      • Radio-Rem
      • Olio-Phlogosis
    • Report of the Council on Pharmacy and Chemistry
    • Radio-Rem
    • Olio-Phlogosis
    • THE HYPOPHOSPHITE FALLACY
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PULVOIDS CALCYLATES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SULFURYL MONAL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MARK WHITE GOITER SERUM AND MARK WHITE IODINIZED OIL
      • Report of the Council on Pharmacy and Chemistry
      • Editorial Note on the Mark White “Serum”
    • Report of the Council on Pharmacy and Chemistry
    • Editorial Note on the Mark White “Serum”
    • KORA-KONIA
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • THE THERAPEUTIC VALUE OF THE GLYCEROPHOSPHATES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HYDRAS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • BROMIN-IODIN COMPOUND
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • AMMONIUM HYPOPHOSPHITE OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ALPHOZONE OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CALCIUM GLYCEROPHOSPHATE AND SODIUM GLYCEROPHOSPHATE OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • GARDNER’S SYRUP OF AMMONIUM HYPOPHOSPHITE OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • GLUTEN PRODUCTS MADE BY THE KELLOGG FOOD COMPANY
      • Report of the Council on Pharmacy and Chemistry
      • Referee’s Report
    • Report of the Council on Pharmacy and Chemistry
    • Referee’s Report
    • IODO-MANGAN OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • LIQUID ALBOLENE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • NAPHEY’S MEDICATED UTERINE WAFERS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • NUJOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PULVOIDS NATRIUM COMPOUND
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SALOFORM
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SECRETOGEN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • IRON CITRATE GREEN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ASPIRIN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PIL. CASCARA COMPOUND-ROBINS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CASTA-FLORA
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FIRWEIN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FIROLYPTOL PLAIN AND FIROLYPTOL WITH KREOSOTE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • BINIODOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • COMPARATIVE SYMPTOMS RESULTING FROM THE USE OF SEVERAL OILY SUSPENSIONS OF RED MERCURIC IODID (MERCURY BINIODID)
      • Report of Dr. H. N. Cole[D]
      • Report of Dr. Albert Keidel
    • Report of Dr. H. N. Cole[D]
    • Report of Dr. Albert Keidel
    • CORPORA LUTEA (SOLUBLE EXTRACT), PARKE, DAVIS & CO.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • WHEELER’S TISSUE PHOSPHATES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • WHEELER’S TISSUE PHOSPHATES
    • THE CLAIMED GALACTAGOGUE EFFECTS OF NUTROLACTIS AND GOAT’S RUE NOT SUBSTANTIATED
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • THE ALLEGED GALACTAGOGUE ACTION OF GALEGA AND NUTROLACTIS [E][F]
    • THE RUSSELL EMULSION AND THE RUSSELL PREPARED GREEN BONE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • BROM-I-PHOS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CREOSOTE-DELSON AND CREOFOS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TRINER’S AMERICAN ELIXIR OF BITTER WINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TRIMETHOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FERRIVINE, INTRAMINE AND COLLOSOL IODINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ESKAY’S NEURO PHOSPHATES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • K-Y LUBRICATING JELLY
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ZIRATOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • GONOSAN
      • Report of the Council on Pharmacy and Chemistry
      • Appendix
    • Report of the Council on Pharmacy and Chemistry
    • Appendix
    • ALCRESTA IPECAC
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • IODEOL AND IODAGOL
      • Report of the Council on Pharmacy and Chemistry
      • Summary of Referee’s Report
    • Report of the Council on Pharmacy and Chemistry
    • Summary of Referee’s Report
    • CAPSULES BISMUTH RESORCINOL COMPOUND NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • DIXON’S TUBERCLE BACILLI EXTRACT AND DIXON’S SUSPENSION OF DEAD TUBERCLE BACILLI
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FORMOSOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • IODOLENE, A SOLUTION OF IODIN IN LIQUID PETROLATUM, INADMISSIBLE TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • KALAK WATER
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MINSON’S SOLUBLE IODIN “KELPIDINE” NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • NUTONE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TRI-ARSENOLE, L. O. COMPOUND NO. 1 AND L. O. COMPOUND NO. 2
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • UNCTOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • V-E-M (SCHOONMAKER LABORATORIES, INC.)
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HEMO-THERAPIN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • VENOSAL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SECRETIN-BEVERIDGE AND THE U. S. PATENT LAW
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • THE QUESTION OF THE STABILITY OF SECRETIN
    • NEED FOR PATENT LAW REVISION
      • Report of the Committee on Patent-Law Revision of the Council on Pharmacy and Chemistry of the American Medical Association
    • Report of the Committee on Patent-Law Revision of the Council on Pharmacy and Chemistry of the American Medical Association
    • SURGODINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MEDEOL SUPPOSITORIES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • GUAIODINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SEVERAL “MIXED” VACCINES NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
      • Mixed Vaccines-Abbott
      • Catarrhal Vaccine Combined-Lilly and Influenza Mixed Vaccine-Lilly
      • Influenza Serobacterin Mixed-Mulford
      • Sherman’s Mixed Vaccine No. 40
    • Report of the Council on Pharmacy and Chemistry
    • Mixed Vaccines-Abbott
    • Catarrhal Vaccine Combined-Lilly and Influenza Mixed Vaccine-Lilly
    • Influenza Serobacterin Mixed-Mulford
    • Sherman’s Mixed Vaccine No. 40
    • OPHTHALMOL-LINDEMANN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SILVOL INELIGIBLE FOR N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • KATHARMON
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • IODINIZED EMULSION (SCOTT) AND CREOSOTONIC (SCOTT)
      • Report of the Council on Pharmacy and Chemistry
      • Iodinized Emulsion (Scott)
      • Creosotonic (Scott)
    • Report of the Council on Pharmacy and Chemistry
    • Iodinized Emulsion (Scott)
    • Creosotonic (Scott)
    • CAMPETRODIN AND CAMPETRODIN NO. 2
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CARMINZYM
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PHILLIPS’ PHOSPHO-MURIATE OF QUININE COMP.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • B. IODINE AND B. OLEUM IODINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • B. IODINE PRODUCTS
    • ANTITHYROID PREPARATIONS (ANTITHYROIDIN-MOEBIUS AND THYREOIDECTIN) OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CEPHAELIN AND SYRUP CEPHAELIN-LILLY OMITTED FROM N. N. R. AND SYRUP EMETIC-LILLY NOT ACCEPTED
      • Report of Council on Pharmacy and Chemistry
    • Report of Council on Pharmacy and Chemistry
    • COLALIN OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FORAL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • GRANULAR EFFERVESCENT BROMIDE AND ACETANILID COMPOUND-MULFORD
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HOLADIN AND BILE SALT MIXTURES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • LIQUOR SANTAIVA, S. & D., OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MALTZYME, MALTZYME WITH CASCARA SAGRADA, MALTZYME WITH COD LIVER OIL, MALTZYME FERRATED AND MALTZYME WITH YERBA SANTA OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • METHAFORM OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PINEAL GLAND, RED BONE-MARROW AND THYMUS GLAND AND THEIR PREPARATIONS OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
      • Pineal Gland
      • Red Bone-Marrow
      • Thymus Gland
    • Report of the Council on Pharmacy and Chemistry
    • Pineal Gland
    • Red Bone-Marrow
    • Thymus Gland
    • PIPERAZINE AND LYCETOL OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • STANOLIND LIQUID PARAFFIN OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • WESTERFIELD’S DIGITALIS TABLETS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • XEROFORM-HEYDEN AND BISMUTH TRI­BROM­PHENATE-MERCK OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CREAM OF MUSTARD REFUSED RECOGNITION
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • “PLURIGLANDULAR” MIXTURES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CERELENE NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • COLLOSOL COCAINE NOT ADMITTED TO N. N. R
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CUPRASE NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • COLLOSOL PREPARATIONS
      • Report of the Council on Pharmacy and Chemistry
      • Additional Notes on Collosol Evidence
    • Report of the Council on Pharmacy and Chemistry
    • Additional Notes on Collosol Evidence
    • PULVOIDS CALCYLATES COMPOUND
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PROTEOGENS OF THE WM. S. MERRELL COMPANY
      • Report of the Council on Pharmacy and Chemistry
      • Report of First Referee on Proteogens
      • Report of Second Referee Reviewing Manufacturers’ Reply
    • Report of the Council on Pharmacy and Chemistry
    • Report of First Referee on Proteogens
    • Report of Second Referee Reviewing Manufacturers’ Reply
    • “ARSENOVEN S. S.” AND “ARSENO-METH-HYD”
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HORMOTONE AND HORMOTONE WITHOUT POST-PITUITARY
      • Report of the Council on Pharmacy and Chemistry.
    • Report of the Council on Pharmacy and Chemistry.
    • FORMALDEHYDE LOZENGES
      • Report of the Council on Pharmacy and Chemistry
      • Hex-Iodin
      • Formitol Tablets
      • Cin-U-Form Lozenges
    • Report of the Council on Pharmacy and Chemistry
    • Hex-Iodin
    • Formitol Tablets
    • Cin-U-Form Lozenges
    • LAVORIS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MEDINAL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • OMISSION OF COTARNIN SALTS (STYPTICIN AND STYPTOL) FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MICAJAH’S WAFERS AND MICAJAH’S SUPPOSITORIES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ALKALITHIA
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ARHOVIN OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CHLORON, CHLORAX AND NUMBER “3”
      • Report of the Council on Pharmacy and Chemistry
      • Chloron
      • Chlorax
      • Number “3”
    • Report of the Council on Pharmacy and Chemistry
    • Chloron
    • Chlorax
    • Number “3”
    • ELARSON OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • IODIPHOS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MERVENOL AND ARMERVENOL NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • NORMAL PHENOL SERUM (CANO) AND METHYL-PHENOL SERUM (CANO) NOT ACCEPTED FOR N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SOAMIN OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SOME MIXED VACCINES NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SOMNOFORM
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TABLETS FORMOTHALATES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TRIPLE ARSENATES WITH NUCLEIN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • “ANTI-PNEUMOCOCCIC OIL” AND THE USE OF CAMPHOR IN PNEUMONIA
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • DIAL “CIBA”
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • APOTHESINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • EUMICTINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PLATT’S CHLORIDES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ANTI-TUBERCULOUS LYMPH COMPOUND (SWEENY) AND ANTI-SYPHILITIC COMPOUND (SWEENY)
      • Report of the Council on Pharmacy and Chemistry
      • Anti-Tuberculous Lymph Compound (Sweeny)
      • Anti-Syphilitic Compound (Sweeny)
    • Report of the Council on Pharmacy and Chemistry
    • Anti-Tuberculous Lymph Compound (Sweeny)
    • Anti-Syphilitic Compound (Sweeny)
    • SYRUP LEPTINOL (FORMERLY SYRUP BALSAMEA)
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FORMITOL TABLETS, II
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SUKRO-SERUM AND APHLEGMATOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SUPSALVS NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HYPODERMIC SOLUTION NO. 13, IRON, ARSENIC AND PHOSPHORUS COMPOUND NOT ACCEPTED FOR N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PARATHESIN NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CHLORLYPTUS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • I. DETAILED REPORTS
      • Summarized Reports
    • Summarized Reports
    • II. APPENDIX: SPECIAL REPORTS
    • A. COMPARISON OF CHLORLYPTUS WITH CHLORINATED EUCALYPTOL
      • From the Chemical Laboratory of the American Medical Association
    • From the Chemical Laboratory of the American Medical Association
    • B. THE PERSISTENCE OF THE ACID
      • Reaction of Chlorlyptus in the Body
    • Reaction of Chlorlyptus in the Body
    • C. TOXICITY EXPERIMENTS
    • D. REPORT OF DR. D. RIVAS
    • AQUAZONE (OXYGEN WATER)
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • COAGULEN-CIBA OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FERRIC CACODYLATE OMITTED FROM NEW AND NONOFFICIAL REMEDIES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • LIBRADOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HELMITOL OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SPIROCIDE NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • DIGIFOLIN-CIBA NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SOME OF LOESER’S INTRAVENOUS SOLUTIONS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • “NATIONAL IODINE SOLUTION” NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MON-ARSONE NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • OXYL-IODIDE NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • QUASSIA COMPOUND TABLETS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TOXICIDE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PIL. MIXED TREATMENT (CHICHESTER)
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ATOPHAN OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • UROTROPIN OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
      • Commercial History of Hexamethylenamin
      • Urotropin Marketed Under Unwarranted Therapeutic Claims
      • Urotropin a Brand of Hexamethylenamine, U. S. P.
    • Report of the Council on Pharmacy and Chemistry
    • Commercial History of Hexamethylenamin
    • Urotropin Marketed Under Unwarranted Therapeutic Claims
    • Urotropin a Brand of Hexamethylenamine, U. S. P.
    • STYPTYSATE NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • LIPOIDAL SUBSTANCES (HOROVITZ) NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • YEAST PREPARATIONS AND VITAMIN B CONCENTRATES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
  • PART II CONTRIBUTIONS FROM THE A. M. A. CHEMICAL LABORATORY
  • FOREWORD
    • THE CHEMICAL LABORATORY OF THE AMERICAN MEDICAL ASSOCIATION
    • THE WORK OF THE AMERICAN MEDICAL ASSOCIATION CHEMICAL LABORATORY[G]
    • LEAD IN “AKOZ”
      • Details of Analysis
    • Details of Analysis
    • SODIUM ACETATE IN WARMING BOTTLES
    • ANTI-SYPHILITIC COMPOUND (SWEENY)
    • “AMBRINE” AND PARAFFIN FILMS[H]
      • Addenda
    • Addenda
    • THE STABILITY OF IODINE OINTMENTS
    • IODOLENE AND THE SOLUBILITY OF IODIN IN LIQUID PETROLATUM
    • AMERICAN-MADE SYNTHETIC DRUGS—I
      • Examination of American-Made Acetylsalicylic Acid
    • Examination of American-Made Acetylsalicylic Acid
    • THE STANDARDIZATION OF COMMERCIAL BISMUTH TRIBROMPHENATE
      • Report to Council of National Defense
      • Revision of N. N. R. Standards
    • Report to Council of National Defense
    • Revision of N. N. R. Standards
    • THE STANDARDIZATION OF PROCAIN AND EXAMINATION OF THE MARKET SUPPLY
    • DETERIORATION OF SODIUM HYPOCHLORITE SOLUTIONS (“Chlorinated Soda” Solutions)
    • SYPHILODOL
      • Details of Analysis
    • Details of Analysis
    • CERELENE
    • DR. DE SANCTIS’ RHEUMATIC AND GOUT PILLS
    • IODEX AND LIQUID IODEX
      • Details of Analysis
    • Details of Analysis
    • I. G. O.
    • IODIN IN LIQUID PETROLATUM
    • AMERICAN-MADE SYNTHETIC DRUGS—II
      • Examination of Procain (Novocain), Barbital (Veronal), Phenetidyl-Acetphenetidin (Holocain), Cinchophen or Phenyl­cinchoninic Acid (Atophan), Manufactured Under Federal Trade Commission Licenses[I][J]
    • Examination of Procain (Novocain), Barbital (Veronal), Phenetidyl-Acetphenetidin (Holocain), Cinchophen or Phenyl­cinchoninic Acid (Atophan), Manufactured Under Federal Trade Commission Licenses[I][J]
  • PART III CONTRIBUTIONS FROM THE JOURNAL: PROPRIETARY PRODUCTS
    • NOSTRUMS IN RETROSPECT
      • A Series of Nine Articles Reviewing Worthless or Unscientific Proprietary Mixtures Previously Criticized
    • A Series of Nine Articles Reviewing Worthless or Unscientific Proprietary Mixtures Previously Criticized
    • [Article I]
      • Bell-Ans (Pa-Pay-Ans Bell)[K]
    • Bell-Ans (Pa-Pay-Ans Bell)[K]
    • [Article II]
      • Anasarcin and Anedemin
    • Anasarcin and Anedemin
    • [Article III]
      • Pepto-Mangan
    • Pepto-Mangan
    • [Article IV]
      • Cactina Pillets
    • Cactina Pillets
    • [Article V]
      • Ammonol and Phenalgin
    • Ammonol and Phenalgin
    • [Article VI]
      • Fellows’ Syrup, and Other Preparations of the Hypo­phosphites
    • Fellows’ Syrup, and Other Preparations of the Hypo­phosphites
    • [Article VII]
      • Shotgun Nostrums
    • Shotgun Nostrums
    • [Article VIII]
      • Tyree’s Antiseptic and Aseptinol
    • Tyree’s Antiseptic and Aseptinol
    • [Article IX]
      • Neurosine and the Original Package Evil
    • Neurosine and the Original Package Evil
    • ANASARCIN ADVERTISING[L]
    • ANTIMERISTEM-SCHMIDT
    • ANTIPHLOGISTINE
    • “AUTO-HEMIC SERUM”
      • A Cure for Laziness, Ugliness, Frigidity and Many Other Things
    • A Cure for Laziness, Ugliness, Frigidity and Many Other Things
    • “AUTOLYSIN” ADVERTISING
    • “BASIC CANCER RESEARCH” AND “COSMOPOLITAN CANCER RESEARCH SOCIETY”
      • Seleni-Bascca
      • Repudiated by the Brooklyn Bureau of Charities
    • Seleni-Bascca
    • Repudiated by the Brooklyn Bureau of Charities
    • BELL-ANS (PAPAYANS, BELL)[M]
      • As the New York Tribune’s “Ad-Visor” Sees It
    • As the New York Tribune’s “Ad-Visor” Sees It
    • CAMPHO-PHENIQUE
      • Appealing to the New Fledged Graduate.
    • Appealing to the New Fledged Graduate.
    • “CINCHOPHEN”: FORMERLY “ATOPHAN”
    • “COLLOSOLS”: AN UNCRITICAL ENGLISH ENDORSEMENT
      • Collosol Manganese
    • Collosol Manganese
    • COTTON PROCESS ETHER
      • A Note from the Manufacturers
    • A Note from the Manufacturers
    • DIONOL
      • Glorified Petrolatum
    • Glorified Petrolatum
    • THE ELI PRODUCTS OF ELI H. DUNN
    • GLOVER’S CANCER SERUM
      • The Toronto Academy of Medicine Reports Unfavorably on Glover’s Cancer Serum
    • The Toronto Academy of Medicine Reports Unfavorably on Glover’s Cancer Serum
    • GLYCO-THYMOLINE AND POLIOMYELITIS
    • GLYKERON: COLD STORAGE TESTIMONIALS [N]
    • GRAY’S GLYCERINE TONIC: “WHOSE BREAD I EAT HIS SONG I SING”
    • HAGEE’S CORDIAL OF COD LIVER OIL
    • HYPNO-BROMIC COMPOUND
    • INTRAVENOUS COMPOUND (LOFFLER)
      • Its Composition and the Peculiar Methods by Which It Is Exploited
    • Its Composition and the Peculiar Methods by Which It Is Exploited
    • INTRAVENOUS SPECIALTIES
    • IODEX
    • THE WILLIAM F. KOCH CANCER REMEDY
      • Further Comment
    • Further Comment
    • THE LUCAS LABORATORIES’ PRODUCTS
    • “PHYLACOGENS” [O]
    • PINEOLEUM ADVERTISING METHODS
      • Capitalizing the Name and Position of the President of the American Medical Association
    • Capitalizing the Name and Position of the President of the American Medical Association
    • “PROTEAL THERAPY” AND HENRY SMITH WILLIAMS
    • PROTEOGENS
      • Commercial Therapeutics [P]
      • An Alleged Endorsement of Proteogens Repudiated
      • The Manufacturer’s Protest and a Reply
      • Details of the Alleged Endorsement of Proteogens
      • Dr. Broeman’s Final Report on Proteogens
    • Commercial Therapeutics [P]
    • An Alleged Endorsement of Proteogens Repudiated
    • The Manufacturer’s Protest and a Reply
    • Details of the Alleged Endorsement of Proteogens
    • Dr. Broeman’s Final Report on Proteogens
    • PULVANE
    • SAL HEPATICA
    • SALICON
    • SO-CALLED SECRETIN PREPARATIONS
    • SUCCUS CINERARIA MARITIMA
      • Another Illustration of One of the Weaknesses of the Federal Food and Drugs Act
    • Another Illustration of One of the Weaknesses of the Federal Food and Drugs Act
    • TEKARKIN
      • Edward Percy Robinson’s “Cure” for Cancer
    • Edward Percy Robinson’s “Cure” for Cancer
    • TYREE’S ANTISEPTIC POWDER AGAIN
      • The “Ethical and Commercial Requirements” of the Drug Business
    • The “Ethical and Commercial Requirements” of the Drug Business
    • WHEELER’S TISSUE PHOSPHATES
    • BRIEFER PARAGRAPHS
      • Alcresta Lotion
      • Calcidin Tablets (Abbott)
      • Di-Crotalin Treatment of Epilepsy
      • Estivin
      • Iron Arsenite
      • K-Y Lubricating Jelly
      • “Nikalgin”
      • Pertussin and Syrup of Thyme
      • Quinin and Urea Hydrochlorid
      • Ricord Pills and House Organ Therapeutics
      • Stannoxyl
      • Syphilodol
      • Thialion
    • Alcresta Lotion
    • Calcidin Tablets (Abbott)
    • Di-Crotalin Treatment of Epilepsy
    • Estivin
    • Iron Arsenite
    • K-Y Lubricating Jelly
    • “Nikalgin”
    • Pertussin and Syrup of Thyme
    • Quinin and Urea Hydrochlorid
    • Ricord Pills and House Organ Therapeutics
    • Stannoxyl
    • Syphilodol
    • Thialion
  • PART IV CONTRIBUTIONS FROM THE JOURNAL: MISCELLANY
    • ALBERT ABRAMS, A.M., M.D., LL.D., F.R.M.S.
      • “Spondylo­therapy,” “Electronic Reactions,” the “Oscilloclast,” the “Electrobioscope,” Etc.
      • Dr. Abrams’ Graduation
      • A Defense by Upton Sinclair
      • Comment
    • “Spondylo­therapy,” “Electronic Reactions,” the “Oscilloclast,” the “Electrobioscope,” Etc.
    • Dr. Abrams’ Graduation
    • A Defense by Upton Sinclair
    • Comment
    • ACETYLSALICYLIC ACID, NOT ASPIRIN
      • “What’s in a Name?”
      • Advertising Principles—Lay and Medical
      • “Aspirin”—A Common Name
      • “Aspirin Bayer” and the Sterling Products Company
    • “What’s in a Name?”
    • Advertising Principles—Lay and Medical
    • “Aspirin”—A Common Name
    • “Aspirin Bayer” and the Sterling Products Company
    • THE ALLIED MEDICAL ASSOCIATIONS OF AMERICA
      • Another Rocket in the Pyrotechnics of Quasimedical Organizations
    • Another Rocket in the Pyrotechnics of Quasimedical Organizations
    • “ARSENICALS”
      • Pharmacology of Arsenicals
      • Salvarsan: Abrogate the Patent
      • End the Monopoly
      • Arsphenamin
    • Pharmacology of Arsenicals
    • Salvarsan: Abrogate the Patent
    • End the Monopoly
    • Arsphenamin
    • BEER AND CANCER CURES
      • Did the Brewing Interests Advertise Autolysin?
    • Did the Brewing Interests Advertise Autolysin?
    • BIOLOGIC THERAPEUTICS AND ITS COMMERCIAL DOMINATION
    • CAPELL’S UROLUETIC TEST
      • Another Urinary Test for Syphilis
    • Another Urinary Test for Syphilis
    • CHEMOTHERAPY AND TUMORS [Q][R]
      • Richard Weil, M.D., New York
    • Richard Weil, M.D., New York
    • THE DIRECT SALES COMPANY
    • DISCOVERIES AND DISCOVERERS
    • “DRUG REFORM”
      • As It Appears to the Cleveland Medical Journal
    • As It Appears to the Cleveland Medical Journal
    • DRUG THERAPY: THE FALLIBILITY OF TEXTBOOKS
    • THOMAS WEBSTER EDGAR
      • Tired Rabbits for Diabetes; Ring-Tailed Monkeys for Sex Stimulation
      • The Journal Receives a Letter Denouncing “Medical Clerks” and “Biased Sceptres”
    • Tired Rabbits for Diabetes; Ring-Tailed Monkeys for Sex Stimulation
    • The Journal Receives a Letter Denouncing “Medical Clerks” and “Biased Sceptres”
    • GLYCEROPHOSPHATES
    • INFLUENZA VACCINES
      • Serums and Vaccines
    • Serums and Vaccines
    • INTRAVENOUS THERAPY
    • IODIN FUMES
    • ITALIAN PHYSICO-CHEMICAL COMPANY
    • WHAT IS LIQUID PETROLATUM?
    • THE LOWENTHAL POSTGRADUATE COURSE
      • Which Tells How to Make Diagnoses Accurately, Scientifically Check the Christian Scientists and Increase Your Earning Power
    • Which Tells How to Make Diagnoses Accurately, Scientifically Check the Christian Scientists and Increase Your Earning Power
    • MEDICAL SOCIETY OF THE UNITED STATES
      • From “Division of Fees” to “Down with Autocracy”
    • From “Division of Fees” to “Down with Autocracy”
    • THE NATIONAL FORMULARY—A REVIEW OF THE FOURTH EDITION
    • NONSPECIFIC PROTEIN THERAPY
    • WILLARD EALON OGDEN
      • A “Specialist in Proctology” and His “Clinics”
    • A “Specialist in Proctology” and His “Clinics”
    • “PATENTS”
      • Patent Laws and Patent Office Practice
      • Our Archaic Patent Laws
      • Patents Perpetuated by Trade Names
      • Patenting Therapeutic Agents
    • Patent Laws and Patent Office Practice
    • Our Archaic Patent Laws
    • Patents Perpetuated by Trade Names
    • Patenting Therapeutic Agents
    • PHARMACEUTICAL BARNUMS
    • THE PHARMACOPEIA
      • The Ninth Decennial Revision
      • Review of Ninth Revision
    • The Ninth Decennial Revision
    • Review of Ninth Revision
    • PHYSICIAN’S STOCK IN PRESCRIPTION PRODUCTS
    • PITUITARY GLAND PREPARATIONS
    • PROPRIETORSHIP IN MEDICINE
      • The Manufacturer’s Protest
      • Why Proprietaries Flourish
    • The Manufacturer’s Protest
    • Why Proprietaries Flourish
    • PHILIP RAHTJEN AND HIS DISCOVERIES
    • SODIUM CACODYLATE IN SYPHILIS
    • TABLETS: DEPENDABILITY OF DOSAGE
    • THERAPEUTIC EVIDENCE: ITS CRUCIAL TEST [S][T]
      • Torald Sollmann, M.D., Cleveland
    • Torald Sollmann, M.D., Cleveland
    • “VACCINES IN TOXIC CONDITIONS”
      • Commercialized Propaganda in the Guise of Science
    • Commercialized Propaganda in the Guise of Science
    • VITAMINS: THEIR DISTRIBUTION
      • Our Knowledge of Vitamins
      • The Demand for Vitamins
    • Our Knowledge of Vitamins
    • The Demand for Vitamins
    • THE WILLIAM A. WEBSTER CO. AND THE DIRECT PHARMACEUTICAL CO.
    • YEAST
      • Yeast and Its Uses
    • Yeast and Its Uses
    • BRIEFER PARAGRAPHS
      • Laxol and Lysol—The Short and Catchy Proprietary Name
      • Look Up Its Rating
      • The Medical Profession and Commercial Interests
      • Rabbit-Foot Therapy
      • Secret Remedies and the Principles of Ethics
      • “Sterling Violet Ray Generator”
      • Strontium Salicylate Not Superior to Sodium Salicylate
      • Vaccine As a Prophylactic in Influenza
      • Vaccines for “Colds”
    • Laxol and Lysol—The Short and Catchy Proprietary Name
    • Look Up Its Rating
    • The Medical Profession and Commercial Interests
    • Rabbit-Foot Therapy
    • Secret Remedies and the Principles of Ethics
    • “Sterling Violet Ray Generator”
    • Strontium Salicylate Not Superior to Sodium Salicylate
    • Vaccine As a Prophylactic in Influenza
    • Vaccines for “Colds”
  • INDEX AND BIBLIOGRAPHY
  • FOOTNOTES:
      No comment for this book yet, be the first to comment
      You May Also Like
      Also Available On
      Categories
      Curated Lists